Kisqali 600 MG daily dose UU 63S

Ended Awarded Last action

Contract number
SPE2DR26F0M1G
Awardee
Awarding agency
Obligated
$24,560

Award facts

Contract value 100% obligated
$24,560.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $24,560 delivery order to AmerisourceBergen Drug Corp on April 16, 2026, for Kisqali (ribociclib) 600 mg daily dose tablets, with ultimate completion by May 7, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. AmerisourceBergen holds a single-award indefinite delivery contract (SPE2DX) with DLA Troop Support Medical valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for military healthcare supply across multiple therapeutic domains.

Quick answers

Who was awarded contract SPE2DR26F0M1G?

SPE2DR26F0M1G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 16, 2026.

How much is contract SPE2DR26F0M1G worth?

The government has obligated $24,560 on SPE2DR26F0M1G.

Is contract SPE2DR26F0M1G an order under another contract?

Yes. SPE2DR26F0M1G is a delivery order under SPE2DR25D3103, an indefinite delivery contract.

Was contract SPE2DR26F0M1G competed?

The extent of competition for SPE2DR26F0M1G was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award